S7 is a short synthetic peptide designed with balanced polar and hydrophobic residues to support structural adaptability. Its compact sequence allows exploration of binding motifs and conformational transitions in model systems. Researchers analyze its folding behavior through spectroscopic and computational approaches. Applications include motif screening, ligand-design development, and structure-activity studies.
CAT No: R2813
Synonyms/Alias:L-Leucine;L-leucyl-L-seryl-L-leucyl-L-isoleucyl-L-threonyl-L-arginyl;853248-13-2;S7 (trifluoroacetate salt);DTXSID40462527;(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More